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Abstract
Background: In settings where sexually transmitted infection (STI) and HIV prevalence is high, the postpartum
period is a time of increased biological susceptibility to pregnancy related sepsis. Enabling women living with
HIV to avoid unintended pregnancies during the postpartum period can reduce vertical transmission and maternal
mortality associated with HIV infection. We describe family planning (FP) practices and fertility desires of
HIV-positive and HIV-negative postpartum women in Swaziland.
Methods: Data are drawn from a baseline survey of a four-year multi country prospective cohort study under the
Integra Initiative, which is measuring the benefits and costs of providing integrated HIV and sexual and reproductive
health (SRH) services in Kenya and Swaziland. We compare data from 386 HIV-positive women and 483 HIV-negative
women recruited in Swaziland between February and August 2010. Data was collected on hand-held personal digital
assistants (PDAs) covering fertility desires, mistimed or unwanted pregnancies and contraceptive use prior to their most
recent pregnancy. Data were analysed using Stata 10.0. Descriptive statistics were conducted using the chi square test
for categorical variables. Measures of effect were assessed using multivariate fixed effects logistic regression model
accounting for clustering at facility level and the results are presented as adjusted odds ratios.
Results: Majority (69.2%) of postpartum women reported that their most recent pregnancy was unintended with no
differences between HIV-positive and HIV-negative women: OR: 0.96 (95% CI) (0.70, 1.32). Although, there were
significant differences between HIV-positive and HIV-negative women who reported that their previous pregnancy
was unwanted, (20.7% vs. 13.5%, p = 0.004), when adjusted this was not significant OR: 1.43 (0.92, 1.91). 47.2% of
HIV-positive women said it was mistimed compared to 52.5%, OR: 0.79 (0.59, 1.06). 37.9% of all women said they do
not want another child. Younger women were more likely to have unwanted pregnancies: OR: 1.12 (1.07, 1.12), while
they were less likely to have mistimed births; OR: 0.82 (0.70, 0.97). Those with tertiary education were less likely to
have unwanted or mistimed pregnancies OR: 0.30 (0.11, 0.86). Half of HIV-positive women and more than a third
of HIV-negative women reported that they had been using a FP method when they became pregnant with no
differences between the groups: OR: 1.61 (0.82,3.41). Only short-acting methods were available to these women before
the most recent pregnancy; and available during the postpartum visit. One fifth of all women received an FP method
during the current visit. Among the four fifths who did not receive a method 17.3% reported they were already using
a method or were breastfeeding. HIV-positive women were more likely to have already started a method than
HIV-negative women (20% vs. 15%, p = 0.089).
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Conclusion: There are few differences overall between the experiences of both HIV-positive and negative women in
terms of FP experiences, unintended pregnancy and services received during the early postpartum period in Swaziland.
Women attending postpartum facilities are receiving satisfactory care. Access to a wider range of effective methods is
urgently needed if high levels of unintended pregnancy are to be reduced among HIV-positive and HIV-negative
women living in Swaziland.
Keywords: Pregnancy, Fertility desires, Postpartum care, Family planning, HIV
Background
In virtually all Sub-Saharan African (SSA) countries, women
have limited access to and use of health care services during
the postnatal period [1]. A lack of clearly defined guidelines
and standards in many countries, including the content and
timing of postnatal care (PNC) for the mother and the baby
up to six weeks after birth, contributes to a discontinuity
with the services received during pregnancy and delivery
[2,3]. In addition, postnatal guidelines do not cover women
delivered by caesarean section, low-birth-weight or preterm
babies, twins, new mothers and babies with certain health
problems, adolescents and women living with human
immunodeficiency virus (HIV) [3]. These gaps can limit
linkages to other key services for new mothers, including
family planning (FP) and HIV care services for women living
with HIV [4].
HIV infection has become an important contributing
cause of maternal mortality in Africa [5,6]. In settings
where the prevalence of sexually transmitted infections
(STIs), and HIV, is high, postnatal period is also a time of
increased biological susceptibility to pregnancy-related
sepsis [7] and the leading cause of maternal mortality.
Women living with HIV are at 1.5 to 2 times greater risk of
dying during pregnancy or childbirth than HIV-negative
women [5,8] and are more likely to suffer from complica-
tions such as postpartum haemorrhage, puerperal sepsis
and complications of caesarean section [9,10].
Globally, almost 90 million women have an unintended
pregnancy each year, largely due to an unmet need for FP
[11]. Providing FP to women in developing countries who
have an unmet need for modern methods would prevent
54 million unintended pregnancies, including 21 million
unplanned births, 26 million induced abortions (of which
16 million would be unsafe) and seven million miscarriages;
this would also prevent 79,000 maternal deaths and 1.1
million infant deaths [11]. In SSA, the unintended preg-
nancy rate is estimated to be 20–40%, but only 21% of
partnered women are using modern contraception and an
estimated 20–35% of women have an unmet need for
contraception [12]. Women are vulnerable to unintended
pregnancy during the three to six months after delivery
when they either reduce or stop exclusive breastfeeding and
their natural fertility returns [13]. It estimated that 73% of
women within one year after birth (the “extended postnatal
period”) have an unmet need for FP [13].
Enabling women living with HIV to avoid unintended
pregnancies during the postpartum period can reduce verti-
cal transmission of HIV and maternal mortality associated
with HIV infection [14]. For this reason, a key component
of the World Health Organization’s (WHO) comprehensive
strategy 2011–2015 for prevention of mother-to-child
transmission (PMTCT) is to increase contraceptive use
among HIV-positive women who wish to use it [15]. More
recently there is emerging evidence of access to and use of
FP by women living with HIV [16-19]. Of importance is
evidence suggesting that in settings of low contraceptive
prevalence, and high HIV prevalence, women living with
HIV in most parts of SSA may have shorter birth spacing
intervals than HIV-negative women [20,21], implying
limited access to FP services following childbirth. However,
there is limited evidence on fertility desires, contraceptive
needs and FP practices of HIV-positive women during the
postnatal period. This paper addresses these gaps by com-
paring fertility desires, family planning practices and receipt
of PNC services among HIV-positive and HIV-negative
post partum women in Swaziland.
Methods
Data for these analyses are drawn from a baseline study of
a four-year multi-country study - the Integra Initiative:
which is measuring the benefits and costs of providing
integrated HIV and sexual and reproductive health services
in Kenya and Swaziland [22]. The study methodology and
intervention is described in detail elsewhere [23]. Respon-
dents were recruited between February and August 2010 as
part of a prospective cohort study designed to measure the
effect of timing and content of an integrated HIV and
PNC/FP services model. This model developed explicit
linkages with FP services and relevant HIV/AIDS services,
for the mother and her baby. The intervention focussed on
strengthening existing postpartum consultations during
pre-discharge, one week, and six-week, additional consulta-
tions were introduced at six months to enable women to
access time-relevant services for themselves and their
babies. Moreover, information about and encouragement to
receive this full package of postpartum services was made
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during antenatal-care consultations to increase continuum
of care of essential services. The services included repeat
HIV testing for mother, HIV testing for infant and referral
to HIV services for HIV positive mothers and infants, as
well as referrals for clients requiring additional services.
To assess the impact of service integration, the cohort of
women were recruited from health facilities where they had
attended for postnatal services and followed over a two year
period. However this paper compares the fertility desires,
family planning practices, information and services received
during postnatal visits including breastfeeding, family
planning counselling and uptake among HIV-positive and
HIV-negative women using only the cross sectional
baseline data.
Ten facilities were purposively selected, based on a
minimum number of postpartum women attending per
month (to be able to achieve the necessary sample sizes)
and the availability of HIV, PMTCT, postpartum, FP and
immunisation services at these facilities. Samples of women
who were at least 18 years old, lived in the facility’s catch-
ment area, had given birth within the previous 0–10 weeks
and were receiving PNC for themselves and/or their babies
were recruited for interview irrespective of their HIV status.
All women attending on the days of data collection were
approached for interview consecutively until the requisite
sample size was reached. The desired sample size of
989 was calculated to test the larger study hypothesis that
exposure to the PNC model of intervention would lead to
an increase in condom use by at least 7 percent among
sexually active women over two years.
A total of 886 women reported that they had been tested
for their HIV status. Of these, 503 women reported being
HIV-negative and 344 reported being HIV-positive;
29 women did not want to disclose their HIV status and 9
had tested but had not received their results. In addition to
using self-reported status of HIV, we sought to validate
these reports by examining responses to other questions to
identify the services that the women had received during
their previous antenatal or current postnatal visits. This
process indicated that 42 women who self-reported as
being HIV-negative had received HIV related services,
suggesting that they were HIV-positive. This paper com-
pares data from the subset of 386 women self-reporting as
HIV-positive or assumed to be HIV-positive because of
their use of HIV services, with the subset of 483 women
self-reporting as HIV-negative and who had not used any
HIV services. For the combined sample size of 869 women,
the proportion of 44% considered to be HIV-positive
mirrors the national HIV prevalence rate.
Each eligible respondent, willing to be interviewed, gave
their informed consent prior to being interviewed. Teams
of trained research assistants conducted the interviews
using hand-held personal digital assistants (PDAs) loaded
with the questionnaire translated from English into
siSwati. The closed-ended questions on fertility desires
focussed on the number of children born, whether the
woman would like to have another child or not, their
desired number of children and when they would like to
have their next child. Mistimed or unwanted pregnancies
were determined by asking whether, during the last preg-
nancy, the respondent wanted to be pregnant then,
wanted to wait until later or did not want any more
children.
Women were asked whether they were using any form
of contraceptive method prior to their most recent preg-
nancy and if so which one(s). In addition, they were asked
whether they had received any methods during the
current visit, their preferred methods and the provider’s
actions around FP counselling and service delivery.
Women were also asked about their use of postpartum
and postnatal services and previous use of STI/HIV
services, including their knowledge of STI/HIV counsel-
ling and testing services and whether the provider offered
counselling and testing for HIV during the current visit,
whether the women accepted the test and if not why.
Subsequently they were asked if they had been tested
before and whether they had received the test results and
were willing to disclose their status. The interviewers
reiterated that providing this information was entirely
optional and their response would be kept strictly confi-
dential as no names or other identifiers were recorded on
the data collection instrument; respondents were told that
not disclosing their status was not a criterion for exclusion
from the study and would not affect their ability to
access services at the facility.
Statistical analysis
Data recorded on the PDAs were imported into Microsoft
Access and then into Stata 10.0 for analysis. All statistical
tests were two-tailed, and interpreted at a 5% confidence
level. Two methods of analysis were used. First, FP
practices and service use by HIV-positive women was
compared according to the time when they learnt their
status in order to determine whether knowledge of being
HIV-positive was an influence. Secondly, service use by all
women was compared by the women’s HIV status. In both
approaches, descriptive statistics were conducted using
the chi square test for categorical variables; Fisher’s exact
test was used for small cell sizes (<5) and aT-test was used
to compare means across two groups.
Measures of effect were assessed using multivariate
fixed effects logistic regression model accounting for
clustering at facility level and the results were presented
as adjusted odds ratios or incidence rate ratios (IRR). The
basic model is given by Equation (1) where πij is the
probability of experiencing the outcome for individual i
identified from facility j ; Xij is the vector of covariates; β is
the associated vector of fixed parameters; and μj are the
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unobserved characteristics of individual identified from
the same facilities.
logit πij
  ¼ Xijβþ μj ð1Þ
The key outcome variables were previous fertility
preferences (unwanted or mistimed births), use of FP
when previous pregnancies was unwanted, future fertility
intentions, and receipt of FP during current visit. The
independent variable of interest was HIV status and was
dichotomized into two categories (1 = HIV-positive and
0 =HIV-negative). The model controlled for education,
marital status, age and whether they knew their HIV status
before or after index pregnancy.
Ethical issues
Researchers were trained on conduct of ethical procedures
and monitored during fieldwork. We obtained informed
consent for each study participant. All participants were
given detailed information about the study including:
aims, methods of study; institutional affiliations of the
research; anticipated benefits, risks/discomfort and follow-
up of the study; the length of the interview; the choice of
not answering any questions and the right to abstain from
participating in the study, or to withdraw from it at any
time, without reprisal; measures were taken to ensure
confidentiality and anonymity of information provided;
the conduct of interviews in places of the participant’s
choosing to maximize audio privacy; contact details of the
study coordinator for any questions or concerns.
The study was approved by the Scientific Ethics Commit-
tee of the Swaziland Ministry of Health (MOH) (approval
number MH/599C), the Ethics Review Committee of the
London School of Hygiene & Tropical Medicine (LSHTM)
(approval number 5426) and the Population Council
institutional review board (IRB approval number 444). The
Integra Initiative is registered on the Clinical Trials registra-
tion site: ClinicalTrials.gov Identifier: NCT01694862.
Results
Characteristics of women attending postnatal services
Table 1 describes the characteristics of women by HIV
status whose ages ranged from 18 to 45 years and who
attended for postnatal services for themselves or their
infant on the day of interview. The parity among HIV-
positive women was significantly higher than HIV-
negative women when adjusted for age [p < 0.001]. This is
also reflected by their age distribution with HIV-positive
women being significantly older than HIV-negative
women by two years [p < 0.001]. Desired family size was
identical for HIV-positive and negative women, although
there were differences between HIV-positive women in
regard to when they found out their HIV status; women
who knew their status before the most recent pregnancy
desired 3.3 children compared to 2.5 for women finding
out during the last pregnancy [p = 0.010].
Almost all women (99.4%) had attended ANC services
for the most recent pregnancy. However, HIV-positive
women were significantly more likely to have attended
for ANC services during the first trimester (1–3 months)
of pregnancy [p = 0.002], especially those who knew their
status before this pregnancy. Similarly high proportions
(about 86%) of HIV-positive and HIV-negative women
had given birth in a health facility.
Fertility preferences
Over two thirds of the women interviewed reported that
their pregnancy had been unintended, that is, either
unwanted or mistimed i.e. occurred earlier than desired,
with similar proportions among HIV-positive and HIV-
negative women with no significant differences between
the two groups (Table 2).
There were significant differences between HIV-positive
and HIV-negative women regarding the nature of their
unintended pregnancy (Table 2), although more women
living with HIV reported that it had been unwanted, when
adjusted, the differences were not significant (Table 3).
Fewer HIV-positive women reported a mistimed preg-
nancy [p = 0.005]. However, when adjusted for clustering
and other variables, the likelihood of a mistimed birth
reduces with increasing age: OR: 0.94, 95% CI (0.95, 0.96),
[p = 0.009]. Women who were single and in relationship
were to times likely to have a mistimed birth: OR: 2.05
(1.43, 2.81); [p < 0.001].
Younger women were more likely to have unwanted
pregnancy; OR: 1.12, (1.07, 1.12); [p = 0.042], this was
also the case for single or divorced women and single
women in relationship: OR; 13.23 (2.67, 71.12), [p =
0.003] and OR; (1.76 (1.12, 2.76), [p = 0.001] respectively.
Women who were either single and in a relationship or
single living with a partner were three or two times
likely to have an unintended pregnancy; OR: 3.51, (2.47,
4.98); [p < 0.001] and OR: 1.76, (1.12, 2.71), [p = 0.034].
Women with tertiary education were less likely to have
an unwanted or mistimed births OR: 0.33 (0.11, 0.86),
[p < 0.001] (Table 3).
One third of all women who had indicated an unwanted
pregnancy reported that they had been using a FP method
when they became pregnant; moreover, this proportion
was not significantly different both at descriptive and
when adjusted: 62.5% among HIV-positive and 47.7%
among HIV-negative women [p = 0.074]. The majority of
these women had used a short term method (condom,
hormonal pill or injectable). For those reporting an un-
wanted pregnancy, HIV-positive women were more likely
than HIV-negative women to be using male condoms and
less likely to be using hormonal pills. More than half
[59.2%] of all women who indicated a mistimed pregnancy
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reported they were using a short term FP method when
they became pregnant with 65.1% of HIV-positive women
stating this compared to 36.9% of HIV-negative women.
However there were no significant differences by HIV
status on type of FP method used. Over a third of all
women stated they did not want another child with no
differences by HIV status.
Information and services for maternal and child health
during postnatal visit
Over 40% of all women with no differences by HIV
status reported receiving information from health service
providers on the importance of waiting for at least two
years before thinking about another pregnancy during
the current visit. But fewer reported receiving informa-
tion on when to expect return of menses, return of
fertility or advice on when to commence sexual activity
following childbirth (Table 4). There were no significant
differences in information received by HIV status. The
majority of HIV-positive women (89.4%) said they
received information on infant feeding and were more
likely than HIV-negative women (84.5%) to receive this
information, especially those who knew their HIV status
prior to the most recent pregnancy (95.1%). Less than a
fifth of all women interviewed received any information
on which danger signs they should look for in the
newborn or very young infant. Examples of these signs
include difficulty breathing, difficulty feeding, high or
Table 1 Socio-demographics profile of postpartum women
HIV-positive HIV-negative All women P value*
Age (years) 386 (%) 483 (%) 869 (%)
18-25 175 (45.3) 315 (65.2) 490 (56.4)
<0.001
26-30 129 (33.4) 91 (18.8) 220 (25.3)
31-35 61 (15.8) 41 (8.5) 102 (11.7)
36-45 21 (5.4) 36 (7.5) 57 (6.6)
Pregnancies
Average number of pregnancies (SD) 2.9 (1.5) 2.4 (1.6) 2.6 (1.6) <0.001
Average number of desired children (SD) 2.6 (1.4) 2.6 (1.2) 2.6 (1.3) 0.845
Marital status
Single divorced 4 (1.0) 4 (0.8) 8 (0.9)
0.042
Single in relationship 160 (41.5) 245 ( 50.7) 405 (46.6)
Single living with partner 47 (12.2) 42 (8.7) 89 (10.2)
Married 175 (45.3) 192 (39.8) 367 (42.2)
Education
None 25 (6.5) 16 (3.3) 41 (4.7)
0.001
Primary 126 (32.6) 115 (23.8) 241 (27.7)
Secondary 224 (58.0) 327 (67.7) 551 (63.4)
Tertiary 11 (2.8) 25 (5.2) 36 (4.1)
Religion
None 18 (4.7) 20 (4.1) 38 (4.4)
0.929Christian 325 (84.2) 408 (84.5) 733 (84.3)
Traditional 43 (11.1) 55 (11.4) 98 (11.3)
When started antenatal care 362 432 794
1 to 3 months 87 (24.0) 67 (15.5) 154 (19.4) 0.002
4 to 6 months 248 (68.5) 325 (75.2) 573 (72.2) 0.035
7 to 9 months 27 (7.5) 40 (9.3) 67 (8.4) 0.363
Place of index pregnancy delivery 386 483 869
Health facility 331 (85.8) 424 (87.8) 720 (86.8)
0.407
Home 46 (11.9) 54 (11.2) 95 (11.5)
TBA/Relative 2 (0.5) 2 (0.4) 4 (0.5)
On the way 7 (1.8) 3 (0.6) 9 (1.2)
Across all tables*p values compares HIV + and HIV-negative women.
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low temperature, jaundice and abnormal crying. There
were no significant differences between HIV-positive
and HIV-negative women for these indicators.
Breastfeeding and use of FP
The vast majority of recently delivered women (90.9%)
said they were exclusively breastfeeding their infants
after childbirth, with significantly higher proportions of
HIV-negative women (93.4%) than HIV-positive women
(87.8%) (Table 3). However, HIV-positive women who
knew their status before this pregnancy were more likely
to breastfeed their babies and less likely to give replace-
ment feeds than women who discovered they were HIV-
positive during their pregnancy.
Among these women, 20.2% of HIV-positive and
18.8% of HIV-negative women had resumed sex since
childbirth (Table 4), with approximately eight percent of
all women having had sex within the first four weeks,
with no difference by HIV status (data not in table).
Two thirds of sexually active postpartum women were
exclusively breastfeeding (and not using FP) less than
one third were both breastfeeding and using FP. Among
those not breastfeeding, five women were using FP;
another five were neither using FP nor breastfeeding
and so theoretically at risk of an unintended pregnancy
because of an unmet need for contraception.
Family planning counselling and uptake
The majority of all women reported having discussed FP
with the provider during their visit; this proportion was
significantly higher for HIV-positive women (76%) than
for HIV-negative women (66%). Approximately one-fifth
Table 2 Fertility preferences and pre-pregnancy use of FP methods among postpartum women
HIV-positive HIV-negative Total P value*
Previous fertility preferences 386 (%) 483 (%) 869 (%)
Unwanted or mistimed births 262 (67.9) 339 (70.2) 601 (69.2) 0.464
- Unwanted 80 (20.7) 65 (13.5) 145 (16.7) 0.004
- Mistimed 182 (47.2) 274 (56.7) 456 (52.5) 0.005
Used FP when last pregnancy was 80 65 145
Unwanted 50 (62.5) 31 (47.7) 81 (55.9) 0.074
FP method used when woman became pregnant and did not want pregnancy** 50 31 81
Hormonal pills and condoms 1 (2.0) 0 (0.0) 1 (1.2) 0.428
Hormonal pills only 4 (8.0) 10 (32.3) 14 (17.3) 0.005
Injectables and condoms 1 (2.0) 1 (3.2) 2 (2.5) 0.730
Injectables only 13 (26.0) 9 (29.0) 22 (27.2) 0.766
Implant only 0 (0.0) 1 (3.2) 1 (1.2) 0.201
IUCD only 0 (0.0) 1 (3.2) 1 (1.2) 0.201
Male condoms only 34 (68.0) 10 (32.3) 44 (54.3) 0.003
Withdrawal only 0 (0.0) 1 (3.2) 1 (1.2) 0.201
Used FP when last pregnancy was 182 274 601
Mistimed 82 (45.1) 101 (36.9) 183 (30.4) 0.08
FP used when woman became pregnant with mistimed pregnancy 82 101 183
Hormonal pills only 14 (17.1) 21 (20.8) 35 (19.1) 0.525
Injectable and condoms 2 (2.4) 0 (0.0) 2 (1.1) 0.115
Injectables only 29 (35.4) 35 (34.7) 64 (34.9) 0.920
Male condoms only 42 (51.2) 42 (41.5) 84 (45.9) 0.268
Emergency pills 0 (0.0) 1 (1.0) 1 (0.6) 0.366
Withdrawal and condoms 2 (2.4) 3 (2.9) 5 (2.7) 0.266
Future fertility intentions 386 483 869
Does not want another child 154 (39.9) 175 (36.2) 329 (37.9) 0.268
Length of time to next child 15 42 57
Wants another child within two to three years 1 (6.7) 2 (4.8) 3 (5.3) 0.777
Wants another child after three years 14 (93.3) 40 (95.2) 54 (94.7) 0.777
*** Multiple responses for types of methods used when pregnant.
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of women reported receiving a FP method during the
current visit; there were no significant differences be-
tween HIV-positive and HIV-negative women. The most
frequently received method was the hormonal injectable
(62.0%), followed by the hormonal pill (23.5%), and male
or female condoms (11.5%); three women received a
long-acting or permanent method. Significantly more
HIV-positive than HIV-negative women received con-
doms and significantly fewer received contraceptive pills.
Although not significant, more HIV-positive women were
using a condom with another contraceptive method
compared to HIV-negative women (15.9% versus 8.3%).
Among the four-fifths of women who did not receive a
method during their postnatal consultation, 17.3% reported
that they were already using a short term method. HIV-
positive (20%) women were more likely to have already
started using a method than HIV-negative women (15%),
although this difference was not statistically significant.
Most women (54%) not already using a method or not
starting a method reported that they did not feel ready to
start at this point in time. Seven percent of women reported
wanting to start a method but had experienced a health
system related barrier, such as their choice of method not
being available, a lack of supplies or equipment, the
provider being “too busy”, or being referred elsewhere for
FP, and so are considered to have an unmet need.
Discussion
Our findings show that HIV-positive women were on
average older, more likely to have a higher parity and less
education than HIV-negative women, an observation con-
sistent with findings from other studies in SSA [20,21,24].
Two thirds of this sample of recently delivered women in
Swaziland reported that their most recent pregnancy was
unintended, a high level even for a country of southern Af-
rica where high levels of unintended pregnancy occur [6].
A higher proportion of women reported that the pregnancy
was mistimed rather than unwanted; the proportion
reporting that the pregnancy had been unwanted was sig-
nificantly higher among HIV-positive than HIV-negative
women. As most HIV-positive women had already achieved
their desired family size, this finding is not surprising but
reflects a substantial unmet need for effective contraception
for women wanting no more children.
However, more than half of all postpartum women said
that they had been using a short term FP method when
they became pregnant, and this proportion was signifi-
cantly higher (around three fifths) among HIV-positive
women. Moreover, two-thirds of HIV-positive women
experiencing an unwanted pregnancy and half of those ex-
periencing a mistimed pregnancy were using the condom.
Reliance on condoms for dual protection to prevent both
unintended pregnancy and HIV transmission or re-
infection does not, therefore, appear to be an effective
strategy, a finding supported by other studies [25].
Use of FP method prior to the previous pregnancy and
the FP method available to the women on the day of
interview are similar. The majority of methods available
to this group of women are short term methods: hormo-
nal pills, injectables and condoms even though a sizable
number report not wanting any more children. Among
women reporting that the last pregnancy was unwanted,
it is not known whether their use of a short-acting, less
effective method was because of preference for such
methods or because of the limited availability of longer-
acting, more effective methods. Methods such as the
implant, intra-uterine device and sterilization are not
readily available in Swaziland’s public health facilities
[26], indeed, hormonal implants were only introduced
in late 2010 (personal communication 2011 with Head
of Sexual and Reproductive Health Unit ,Ministry of
Health). The intra-uterine device is only available if
Table 3 Relationship between pregnancy intentions, pre-pregnancy use of FP methods and socio-demographics
Unwanted
pregnancy Mistimed birth
Unwanted or
mistimed birth
Use of FP when last
pregnancy was unwanted
Use of FP when last
pregnancy was mistimed
HIV status (HIV positive = 1) 1.43 (0.92, 1.91) 0.79 (0.59, 1.06) 0.96 (0.70.1.32) 1.61 (0.82,3.41) 1.32 (0.91,2.02)
Age (range 18–45 years) 1.12** (1.07,1.12) 0.82** (0.70,0.97) 1.23* (1.02,1.47) 1.16* (1.04,1.12) 1.02 (0.91,1.13)
Period of knowing HIV status
(before index pregnancy =1)
1.34 (0.72,2.81) 0.81 (0.66,1.00) 0.86 (0.69,1.04) 0.57 (0.13,1.72) 0.65 (0.21,1.72)
Education
Primary level 0.95 (0.42,1.90) 0.84 (0.42,1.70) 0.64 (0.28,1.46) 2.42 (0.6,10.7) 0.83 (0.26,2.17)
Secondary level 0.65 (0.34,1.32) 0.91 (0.46,1.77) 0.58 (0.26,1.30) 1.94 (0.56,8.11) 1.23 (0.52,3.21)
Tertiary 0.23 (0.04,1.04) 0.69 (0.27, 1.79) 0.30* (0.11,.0.86) NA 1.92 (0.23,2.13)
Marital status
Single divorced 13.23* (2.67,71.12) 0.45 (0.08,2.35) 5.22 (0.62,43.3) 0.87 (0.12,5.91) NA
Single in relationship 1.76* (1.12, 2.71) 2.06** (1.51,2.82) 3.51** (2.47, 4.98) 1.73 (0.72,4.31) 0.61 (0.31.0.91)
Single living with partner 1.23 (0.61, 2.41) 1.53 (0.94,2.50) 1.69* (1.02.2.82) 0.94 (0.23,3.81) 1.08 (0.51,2.06)
*p < 0.05; **p < 0.01.
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there is a skilled provider within the facility (often only
one individual) and sterilization through referral to a
higher level facility.
Service providers frequently miss opportunities to
counsel all women, including those living with HIV, on
the full range of contraceptive methods [20]. Some
Table 4 Postpartum and postnatal service use among postpartum women by HIV status
Providers gave information on:
HIV-positive HIV-negative Total P value*
213 (%) 304 (%) 517 (%)
Waiting before getting pregnant 92 (43.2) 127 (41.8) 219 (42.4) 0.748
383 482 865
Return to menstruation 71 (18.4) 81 (16.8) 152 (17.5) 0.506
386 483 869
Return to sexual activity 52 (13.4) 54 (11.8) 106 (12.2) 0.305
Infant feeding practices 345 (89.4) 408 (84.5) 753 (86.7) 0.035
385 478 863
Return to fertility 75 (19.5) 79 (16.5) 154 (17.8) 0.260
386 479 862
Danger signs in babies 59 (15.4) 92 (19.2) 151 (17.5) 0.145
360 429 789
FP after birth 273 (75.8) 281 (65.5) 554 (70.2) 0.002
Infant feeding practices 386 483 869
Exclusive breast feeding 339 (87.8) 451 (93.4) 790 (90.9)
<0.001Replacement feeding 46 (11.9) 8 (1.7) 54 (6.2)
Mixed feeding 1 (0.3) 24 (6.2) 25 (2.9)
Resumed sexual activity 78(20.2) 91(18.8) 169(19.5) 0.613
% sexually active 78 91 169
Breastfeeding and not using FP *** 49 (62.8) 62 (68.1) 111 (65.6) 0.468
Breastfeeding and using a FP method 24 (30.7) 24 (26.4) 48 (28.4) 0.528
Not breastfeeding and not using FP 4 (5.1) 1 (1.1) 5 (2.9) 0.123
Percent of women who 386 483 869
Received FP method during visit 69 (17.9) 97 (20.1) 166 (19.1) 0.411
Methods received during current visit† 69 97 166
Hormonal pills only 10 (14.5) 29 (29.9) 39 (23.5) 0.021
Injectables only 45 (65.2) 58(59.8) 103 (62.0) 0.478
Male condoms only 11(15.9) 6 (6.1) 17 (10.2) 0.041
Female condoms 5 (7.2) 3 (3.1) 8 (4.8) 0.218
Condoms with another method 11 (15.9) 8 (8.3) 19 (11.5) 0.125
Intra uterine device 1 (1.5) 0 (0.0) 1 (0.6) 0.234
Female sterilization 0 (0.0) 1 (1.0) 1 (0.6) 0.398
Implants only 0(0.0) 1 (1.0) 1 (0.6) 0.398
Reasons for not receiving method 316 385 701
Already using FP 63 (19.9) 58 (15.1) 121 (17.3) 0.089
Not ready for a method 166 (52.5) 213 (55.3) 379 (54.1) 0460
Health system factors 16 (5.1) 34 (8.8) 50 (7.1) 0.054
Personal factors 9 (2.8) 7 (1.8) 16 (2.3) 0.364
Others 62 (19.6) 73 (19.0) 135 (15.5) 0.826
*** Breastfeeding cases include only those that are exclusively breastfeeding while FP users is derived from those already in a method and those who received a
method during the current visit.
† Multiple responses.
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studies have demonstrated that long acting methods are
not necessarily recommended by providers or accessible
to women living with HIV due to limited knowledge of
the health care workers providing HIV services know-
ledge and counselling skills; lack of commodities oper-
ational guidelines and poorly integrated reproductive
health/FP and HIV services [27]. Nevertheless, a study in
Rwanda demonstrated an increase in use of implants
among HIV-positive women (who had recently given
birth) when access was improved [28,29], suggesting that
this intervention is both feasible and acceptable.
Although a substantial proportion of women received
information from health care providers on delaying their
next pregnancy for at least two years and on FP, few
received information on when to expect return to fertility
and menses. At the time of interview many reported using
a contraceptive method prior to the postnatal visit,
received an FP method in the current visit or reported
exclusively breastfeeding and so do not, according to some
definitions, have an unmet need for FP. However if women
are not clear when their fertility is likely to return these
women will be potentially at risk in a few months time.
A few women had resumed sexual activity following
childbirth but were not exclusively breastfeeding and so
natural fertility is likely to return soon. In addition a
proportion of non breastfeeding women were also not
using any contraception. The likelihood of becoming
pregnant again in the next three to six months is high as
found in other studies [13]. This demonstrates that
women receive information on FP but are only receiving
short term methods even though majority do not want
any more children.
One key limitation of this study is the fact that the
study population of postpartum women attending a health
facility is not representative of the general postpartum
population in Swaziland, as only 25% of newly delivered
women attend for PNC [26]. However the findings do
reflect the services received by recently delivered women
in most public health facilities in Swaziland. Another
limitation is that HIV status was self-reported by the inter-
viewees and validated through referencing other questions
on use of HIV services and not through the maternal card
or through health facility records. The proportion of
women determined to be HIV-positive (44.4%) reflects the
HIV prevalence among pregnant women in the country,
which was 42 percent in 2008 [26], thus suggesting that
this measure is probably valid.
Conclusion
There are few differences overall between the experiences
of both HIV-positive and HIV-negative women in terms
of use of FP experiences, of unintended pregnancy and
services received during the postpartum period. However,
key differences do exist. HIV-positive women appear more
likely to have an unwanted pregnancy and less likely to
have a mistimed pregnancy than HIV-negative women.
HIV-positive women were also more likely to have used
condoms prior to the unwanted pregnancy. The women
were in the first few weeks after delivery, and therefore
due to the high proportion of women who are breast-
feeding and not sexually active indicates that these women
are indeed protected against another pregnancy immedi-
ately. This indicates that women in the period following
childbirth in Swaziland are receiving satisfactory care.
However, the main weakness is the lack of access or avail-
ability of long acting and permanent methods, given the
high proportion of women having unintended pregnancies
and not wanting any more children.
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